We all want good quality in health care and to see quality regularly improving. But many issues have been raised about either the development or application of various quality measures. An article in the Journal of the American Medical Association examines a measure regarding prevention of venous thromboembolism and finds that surveillance bias undermines the utility of the measure. (JAMA Article) Surveillance bias exists when variation in scores or results is due variation in screening or looking for the thing to be measured. In this example, a hospital that is more aggressive in looking for and identifying potential VTE cases, will likely find more and therefore end up with a worse score on the quality measure. Paradoxically, a hospital that didn’t look at all might have fewer cases and a better score, but would clearly be delivering worse care to its patients. The researchers’ analysis included a general quality measure for the hospital, rates of VTE prophylaxis and hospital risk-adjusted VTE rates. Medicare data was the primary information source. Overall hospitals have high compliance with VTE prophylaxis, around 94.5%. As might be expected, hospitals with a higher general quality measure had higher VTE prophylaxis rates. But those with higher prophylaxis rates also had higher VTE event rates. There was an unexpected association between supposed higher quality and worse outcomes. But the higher quality hospitals also had much higher rates of VTE imaging studies, suggesting that they were simply finding more VTEs, not that they actually had more than the lower-quality hospitals. The results should cause policymakers to stop using this quality measure, as it may actually encourage hospital to provide worse care by not looking for VTEs that they then have to report.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace